Literature DB >> 10507603

Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.

M Oberhoffer1, W Karzai, A Meier-Hellmann, D Bögel, J Fassbinder, K Reinhart.   

Abstract

OBJECTIVES: To determine correlations and predictive strength of surrogate markers (body temperature, leukocyte count, C-reactive protein [CRP], and procalcitonin [PCT]) with elevated levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in septic patients.
DESIGN: Prospective consecutive case series.
SETTING: Surgical intensive care unit (ICU) of a university hospital. PATIENTS: A total of 175 patients experiencing intensive care unit stays >48 hrs categorized for sepsis according to ACCP/ SCCM Consensus Conference criteria.
MEASUREMENTS AND MAIN RESULTS: CRP and PCT were both significantly correlated with TNF-alpha and IL-6. Based on the area-under-the-curve of the receiver operating characteristics curves, predicting capability was highest for PCT (0.814 for TNF-alpha >40 pg/mL and 0.794 for IL-6 >500 pg/mL), moderate with CRP (0.732 and 0.716, respectively), and lowest for leukocyte count (0.493 and 0.483, respectively) and body temperature (0.587 and 0.589, respectively). Sensitivity, specificity, positive, and negative predictive values and test effectiveness all followed this same pattern of being highest for PCT followed by CRP, with leukocyte count and body temperature being lowest.
CONCLUSION: PCT may be an early and better marker of elevated cytokines than the more classic criteria of inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507603     DOI: 10.1097/00003246-199909000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  29 in total

1.  Elevated procalcitonin as a diagnostic marker in meningococcal disease.

Authors:  G D Mills; H M Lala; M R Oehley; A B Craig; K Barratt; D Hood; C N Thornley; A Nesdale; N E Manikkam; P Reeve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

2.  [Procalcitonin as an early marker of sepsis].

Authors:  O Thuemer; E Hüttemann; S G Sakka
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

3.  Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis.

Authors:  Gabriela Barrera; Verónica Landoni; Daiana Martire-Greco; Paula Chiarella; Roberto Meiss; Sonia A Gómez; Fernanda Alves-Rosa; Barbara Rearte; Martín Isturiz; Marina S Palermo; Gabriela C Fernández
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

4.  Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis.

Authors:  Tieying Hou; Dehong Huang; Rong Zeng; Zhiming Ye; Yu Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Immunohistochemical expression of tumor necrosis factor-α in sepsis-induced lung injury.

Authors:  Tomoko Miyashita; Nobuyuki Kakimoto; Yuko Ishida; Takahito Hayashi; Akihiko Kimura; Michael Tsokos; Toshikazu Kondo
Journal:  Forensic Sci Med Pathol       Date:  2006-06       Impact factor: 2.007

6.  Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.

Authors:  Dinesh Vyas; Pardis Javadi; Peter J Dipasco; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-09       Impact factor: 3.619

7.  Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.

Authors:  M Oberhoffer; S Russwurm; D Bredle; K Chatzinicolaou; K Reinhart
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

8.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome.

Authors:  Rafael Sierra; Jordi Rello; María Angeles Bailén; Encarnación Benítez; Antonio Gordillo; Cristobal León; Sebastián Pedraza
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

9.  Is C-reactive protein a good prognostic marker in septic patients?

Authors:  Joana Silvestre; P Póvoa; L Coelho; E Almeida; P Moreira; A Fernandes; R Mealha; H Sabino
Journal:  Intensive Care Med       Date:  2009-01-24       Impact factor: 17.440

Review 10.  Tocilizumab in patients with COVID-19: which patient, time, and dose?

Authors:  Ahmed Hasanin; Maha Mostafa
Journal:  J Anesth       Date:  2021-07-15       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.